Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Lowdell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Lowdell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Lowdell Today - Breaking & Trending Today

INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune™, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer - Vimarsana News

INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune™, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer

Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 --... | May 8, 2023

INmune Bio Inc. Announces First Quarter 2023 Results and - Vimarsana News

INmune Bio Inc. Announces First Quarter 2023 Results and

Company to Host Conference Call Today, May 3, at 4:30pm ET...

INmune Bio (INMB) Scheduled to Post Quarterly Earnings on Wednesday - Vimarsana News

INmune Bio (INMB) Scheduled to Post Quarterly Earnings on Wednesday

INmune Bio (NASDAQ:INMB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 3rd. Parties that are interested in participating in the company’s conference call can do so using this link. INmune Bio (NASDAQ:INMB – Get Rating) last released its quarterly earnings data on Thursday, March […]

INmune Bio, Inc. (INMB) Q3 2022 Earnings Call Transcript - Vimarsana News

INmune Bio, Inc. (INMB) Q3 2022 Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:NASDAQ:INMB) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants David Moss - Chief Financial Officer Dr.

-$0.60 Earnings Per Share Expected for INmune Bio, Inc. (NASDAQ:INMB) This Quarter - Vimarsana News

-$0.60 Earnings Per Share Expected for INmune Bio, Inc. (NASDAQ:INMB) This Quarter

Equities analysts expect INmune Bio, Inc. (NASDAQ:INMB – Get Rating) to report earnings of ($0.60) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for INmune Bio’s earnings. INmune Bio reported earnings of ($0.32) per share during the same quarter last year, which would indicate a negative year over […]